cas 1638768-88-3|| where to buy (2,2-Dimethoxycyclobutyl)methanamine

Produktname:(2,2-Dimethoxycyclobutyl)methanamine

IUPAC Name:1-(2,2-dimethoxycyclobutyl)methanamine

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM321889-100mg	in stock	ǭřŽ
CM321889-250mg	in stock	ŁŁŁ
CM321889-1g	in stock	ǎǎǎ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1638768-88-3; Molekulare Formel:C7H15NO2; Schmelzpunkt:-; SMILES-Code:NCC1C(OC)(OC)CC1; Dichte:

: Katalognummer:CM321889; Molekulargewicht:145.2; Siedepunkt:; Mdl-Nr.:MFCD27986944; Lagerung:

: Azetidines; Azetidines are an important class of saturated four-membered nitrogen-containing heterocyclic compounds. The research hotspots related to this structure mainly focus on two aspects: one is the research of pharmaceutical chemistry; the other is related to chiral azetidines, using rigid azetidine compounds as chiral ligands for asymmetric catalytic reactions. Many nitrogen-containing heterocycles play important roles in drug structures, and in many cases small structural changes can improve ligand selectivity and pharmacokinetic properties.; Where to buy Azetidines; Where to buy ADC-Cytotoxins? Chemenu Provide Azetidines with high quality and competitive price. Contact us Now.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.